Literature DB >> 5435231

The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease.

L W Statius van Eps, H Schouten, C C Haar Romeny-Wachter, L W La Porte-Wijsman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5435231     DOI： 10.1016/0009-8981(70)90305-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  10 in total

1.  Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease.

Authors:  Lauren J Becton; Ram V Kalpatthi; Elizabeth Rackoff; Deborah Disco; John K Orak; Sherron M Jackson; Ibrahim F Shatat
Journal:  Pediatr Nephrol       Date:  2010-05-27       Impact factor: 3.714

2.  Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease.

Authors:  Stéphane Maurel; Katia Stankovic Stojanovic; Virginie Avellino; Alexey Girshovich; Emmanuel Letavernier; Gilles Grateau; Laurent Baud; Robert Girot; Francois Lionnet; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

3.  Renal protection by atorvastatin in a murine model of sickle cell nephropathy.

Authors:  Rima S Zahr; Prasanthi Chappa; Hong Yin; Lou A Brown; Kenneth I Ataga; David R Archer
Journal:  Br J Haematol       Date:  2018-03-12       Impact factor: 6.998

4.  Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG).

Authors:  Scott T Miller; Winfred C Wang; Rathi Iyer; Sohail Rana; Peter Lane; Russell E Ware; Daner Li; Renée C Rees
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

Review 5.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

6.  The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design.

Authors:  Bruce W Thompson; Scott T Miller; Zora R Rogers; Renee C Rees; Russell E Ware; Myron A Waclawiw; Rathi V Iyer; James F Casella; Lori Luchtman-Jones; Sohail Rana; Courtney D Thornburg; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada Sarnaik; Thomas H Howard; Lori Luck; Winfred C Wang
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

7.  Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.

Authors:  Paul Drawz; Sabarish Ayyappan; Mehdi Nouraie; Santosh Saraf; Victor Gordeuk; Thomas Hostetter; Mark T Gladwin; Jane Little
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-15       Impact factor: 8.237

8.  Determinants of nocturnal enuresis in homozygous sickle cell disease.

Authors:  D R Readett; J Morris; G R Serjeant
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

Review 9.  Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.

Authors:  Amy Geard; Gift D Pule; David Chelo; Valentina Josiane Ngo Bitoungui; Ambroise Wonkam
Journal:  OMICS       Date:  2016-10

Review 10.  Sickle cell nephropathy: insights into the pediatric population.

Authors:  Oyindamola C Adebayo; Lambertus P Van den Heuvel; Wasiu A Olowu; Elena N Levtchenko; Veerle Labarque
Journal:  Pediatr Nephrol       Date:  2021-05-29       Impact factor: 3.651
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.